Afanat 30 mg Tablet
Request Pricing & Availability
Fill in your details below and our clinical team will get back to you with pricing & availability within 24 hours.
Similar Products
| Product | Manufacturer / Marketed By | Price |
|---|---|---|
Xovoltib 30 mg Tablet
|
Boehringer Ingelheim India Private Limited | Ask for Price |
About our medical review process
Dr. Sophie Reynolds Dr. Sophie Reynolds is a board-certified medical doctor specializing in internal medicine. With over a decade of experience in patient care and medical writing
Description
Afanat 30 mg Tablet contains Afatinib, a targeted cancer medicine used in the treatment of non-small cell lung cancer (NSCLC) that carries specific EGFR (epidermal growth factor receptor) mutations. It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking the signals that promote cancer cell growth and spread. This medicine is prescribed as a first-line therapy for adults with metastatic NSCLC and may also be used in patients who have not responded to prior chemotherapy. Afanat helps slow the progression of cancer, improve symptoms, and extend survival in suitable patients. Key Benefits: Specifically targets EGFR-positive lung cancer cells Slows tumour growth and spread Taken orally once daily Trusted formulation by Natco Pharma Dosage & Administration:Take one tablet daily, or as prescribed by your oncologist. It should be taken on an emp
Related Products
-
Lenvitib 10 mg Capsule
LenvatinibPrice on request
Request pricing -
Lucimird 1 mg Capsule
Price on request
Request pricing -
Luciorfor 17.2 mg Tablet
Price on request
Request pricing -
Luciorfor 14.5 mg Tablet
Price on request
Request pricing -
Luciorfor 9 mg Tablet
Price on request
Request pricing -
Luciorfor 5.5 mg Tablet
Price on request
Request pricing -
Luciorfor 2.5 mg Tablet
Price on request
Request pricing -
Luciorfor 0.8 mg Tablet
Price on request
Request pricing -
LuciPemafib 0.1 mg Tablet
Price on request
Request pricing -
LuciVeric 10 mg Tablet
Price on request
Request pricing -
LuciLemb 5 mg Tablet
Price on request
Request pricing -
LuciElag 200 mg Tablet
Price on request
Request pricing
Related Reading
-
Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, marking another
-
Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026. n This marks an important milestone
-
FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026. n Brain tumors, especially high-grade gliomas,
-
What are the 4 stages of lung cancer?
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 7, 2026. n Lung cancer staging is a
-
Sunvozertinib vs Chemo: A PFS Breakthrough in EGFR+ NSCLC
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 25, 2026. n The treatment landscape for EGFR-mutated
-
Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue
Shipping & Delivery
- Ships from
- India, worldwide delivery
- Order processing
- 1–3 business days after checks
- Transit time
- 5–7 business days by express courier
- Tracking
- Tracking number sent by email or SMS
- Packaging
- Discreet, tamper-evident, cold-chain available
- Duties & taxes
- Payable by the recipient on import
Only logged in customers who have purchased this product may leave a review.


Reviews
Clear filtersThere are no reviews yet.